These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 15744637)

  • 21. Interferon-alpha therapy within the first year after acute hepatitis C infection in hemodialysis patients: efficacy and tolerance.
    Rocha CM; Perez RM; Narciso JL; Ferreira AP; Lemos LB; Medina-Pestana JO; Silva AE; Ferraz ML
    Eur J Gastroenterol Hepatol; 2007 Feb; 19(2):119-23. PubMed ID: 17272996
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mirtazapine versus venlafaxine for the treatment of somatic symptoms associated with major depressive disorder: a randomized, open-labeled trial.
    Kang EH; Lee IS; Chung SK; Lee SY; Kim EJ; Hong JP; Oh KS; Woo JM; Kim S; Park JE; Yu BH
    Psychiatry Res; 2009 Sep; 169(2):118-23. PubMed ID: 19695711
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term treatment and suicidal behavior in severe depression: ECT and antidepressant pharmacotherapy may have different effects on the occurrence and seriousness of suicide attempts.
    Brådvik L; Berglund M
    Depress Anxiety; 2006; 23(1):34-41. PubMed ID: 16315268
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relationship between mirtazapine dose, plasma concentration, response, and side effects in clinical practice.
    Grasmäder K; Verwohlt PL; Kühn KU; Frahnert C; Hiemke C; Dragicevic A; von Widdern O; Zobel A; Maier W; Rao ML
    Pharmacopsychiatry; 2005 May; 38(3):113-7. PubMed ID: 15902580
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mirtazapine naturalistic depression study (in Sweden)--MINDS(S): clinical efficacy and safety.
    Wålinder J; Prochazka J; Odén A; Sjödin I; Dahl ML; Ahlner J; Bengtsson F
    Hum Psychopharmacol; 2006 Apr; 21(3):151-8. PubMed ID: 16444795
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antidepressant drug therapy and suicide in severely depressed children and adults: A case-control study.
    Olfson M; Marcus SC; Shaffer D
    Arch Gen Psychiatry; 2006 Aug; 63(8):865-72. PubMed ID: 16894062
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of mirtazapine in patients with chronic pain and concomitant depression.
    Freynhagen R; Muth-Selbach U; Lipfert P; Stevens MF; Zacharowski K; Tölle TR; von Giesen HJ
    Curr Med Res Opin; 2006 Feb; 22(2):257-64. PubMed ID: 16466597
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mirtazapene: a noradrenergic and specific serotonergic antidepressant.
    Gray R
    Ment Health Care; 1998 Mar; 1(7):233-4. PubMed ID: 9791425
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Hepatitis C, interferon a and depression: main physiopathologic hypothesis].
    Vignau J; Karila L; Costisella O; Canva V
    Encephale; 2005; 31(3):349-57. PubMed ID: 16142050
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of mirtazapine on dehydroepiandrosterone-sulfate and cortisol plasma concentrations in depressed patients.
    Schüle C; Baghai TC; Eser D; Schwarz M; Bondy B; Rupprecht R
    J Psychiatr Res; 2009 Feb; 43(5):538-45. PubMed ID: 18706658
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Depressive disturbances during antiviral therapy in patients with type C hepatitis].
    Ignatova TM; Kinkul'kina MA; Morozov AO; Avdeeva TI; Volkov AV; Tikhonova IuG
    Klin Med (Mosk); 2007; 85(7):58-63. PubMed ID: 17882814
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A placebo-controlled trial of mirtazapine for the management of methamphetamine withdrawal.
    Cruickshank CC; Montebello ME; Dyer KR; Quigley A; Blaszczyk J; Tomkins S; Shand D
    Drug Alcohol Rev; 2008 May; 27(3):326-33. PubMed ID: 18368615
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mirtazapine improves alcohol detoxification.
    Liappas J; Paparrigopoulos T; Malitas P; Tzavellas E; Christodoulou G
    J Psychopharmacol; 2004 Mar; 18(1):88-93. PubMed ID: 15107190
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anxiety and depression after lung transplantation: Mirtazapine as a first-choice agent?
    Fusar-Poli P; Matteo L; Luca de M; Politi P; Cortesi M; Carboni V
    J Psychosom Res; 2007 Jan; 62(1):101. PubMed ID: 17188127
    [No Abstract]   [Full Text] [Related]  

  • 35. Consensus interferon and ribavirin for patients with chronic hepatitis C and failure of previous interferon-alpha therapy.
    Böcher WO; Schuchmann M; Link R; Hillenbrand H; Rahman F; Sprinzl M; Mudter J; Löhr HF; Galle PR
    Liver Int; 2006 Apr; 26(3):319-25. PubMed ID: 16584394
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Suicidal impulses in patients with chronic viral hepatitis C during or after therapy with interferon alpha].
    Rifflet H; Vuillemin E; Oberti F; Duverger P; Lainé P; Garré JB; Calés P
    Gastroenterol Clin Biol; 1998 Mar; 22(3):353-7. PubMed ID: 9762223
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recurrent hyponatremia associated with citalopram and mirtazapine.
    Bavbek N; Kargili A; Akcay A; Kaya A
    Am J Kidney Dis; 2006 Oct; 48(4):e61-2. PubMed ID: 16997047
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Can antidepressants prevent interferon-alpha-induced depression? A review of the literature.
    Galvão-de Almeida A; Guindalini C; Batista-Neves S; de Oliveira IR; Miranda-Scippa A; Quarantini LC
    Gen Hosp Psychiatry; 2010; 32(4):401-5. PubMed ID: 20633744
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term follow-up of interferon-alpha induction and low-dose maintenance therapy in hairy cell leukemia.
    Benz R; Siciliano RD; Stussi G; Fehr J
    Eur J Haematol; 2009 Mar; 82(3):194-200. PubMed ID: 19077050
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Depression in family practice].
    Elstner S; Burian R; Diefenbacher A
    Med Klin (Munich); 2007 Feb; 102(2):141-50; quiz 151-2. PubMed ID: 17323021
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.